MALIGNANT LYMPHOMA
Clinical trials for MALIGNANT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT LYMPHOMA trials appear
Sign up with your email to follow new studies for MALIGNANT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cord blood matching method could expand transplant access for blood cancer patients
Disease control OngoingThis study tests a new approach to stem cell transplants for people with blood cancers like leukemia and lymphoma. Patients receive a combination of umbilical cord blood and stem cells from a family member, with the cord blood chosen based on specific genetic markers rather than …
Matched conditions: MALIGNANT LYMPHOMA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC
-
Muscle weakness may predict transplant success in blood cancer patients
Knowledge-focused OngoingThis study follows 144 blood cancer patients undergoing stem cell transplants to see how muscle function changes and whether it predicts complications like infections, relapse, or survival. Researchers will measure muscle mass and track medical events over time. The goal is to un…
Matched conditions: MALIGNANT LYMPHOMA
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC